HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marta Maycas Selected Research

Collagen Type I (Type I Collagen)

7/2015Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor κB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marta Maycas Research Topics

Disease

3Bone Resorption
03/2017 - 04/2012
1Perinatal Death
02/2015
1Leukemia
02/2015
1Osteosarcoma (Osteogenic Sarcoma)
06/2013

Drug/Important Bio-Agent (IBA)

1Streptozocin (Streptozotocin)FDA Link
03/2017
1collagen type I trimeric cross-linked peptideIBA
07/2015
1LigandsIBA
07/2015
1Collagen Type I (Type I Collagen)IBA
07/2015
1CateninsIBA
02/2015
1parathyroid hormone-related protein (107-111)IBA
06/2013
1parathyroid hormone-related protein (107-139)IBA
04/2012